Komori
Other Disclosures6090Human Metabolome Technologies,Inc.Information and Communications, Services and Others

Launch of a customer-partnered service supporting productivity improvements in “bio-manufacturing”

The Company launched a customer-partnered service that combines metabolome analysis with newly developed metabolic flux analysis to optimize culture conditions and media for bio-manufacturing companies and researchers, supporting productivity improvements and cost reductions.

Worth reading
60In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Announced details

『バイオものづくり』生産性向上支援サービス
Applicable field (uses covered by this announcement)

バイオ燃料、バイオプラスチック、培養肉、人工タンパク質、食品、機能性素材、バイオ医薬品、細胞治療などのバイオものづくり

Launch date2025年7月28日(リリース、実績)
What the company reported numerically
Usage history

複数の企業がパイロット導入(累計か時点かは不明)

Impact on Business Performance

The impact on our financial results is minor.

The company does not address Contract Value / Offering price.

Source (materials cited by the company)

経済産業省商務・サービスグループ生物化学産業課『バイオ政策の方向性について』

Announced details
ItemDetails
Names of Products / Services Covered『バイオものづくり』生産性向上支援サービス
Launch date2025年7月28日(リリース、実績)
Applicable areaバイオ燃料、バイオプラスチック、培養肉、人工タンパク質、食品、機能性素材、バイオ医薬品、細胞治療などのバイオものづくり
Usage history複数の企業がパイロット導入(累計か時点かは不明)
Impact on Business PerformanceThe impact on our financial results is minor.
Source経済産業省商務・サービスグループ生物化学産業課『バイオ政策の方向性について』
Items this document does not state (12)
CounterpartyCounterparty overviewRelationship with the CompanyContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative Effects

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

バイオものづくりに取り組む企業や研究者に共通する課題である、目的物質の生産性向上によるコスト削減を支援するため。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Launch of a customer-partnered service supporting productivity improvements in “bio-manufacturing” | Human Metabolome Technologies,Inc. (6090) timely disclosure | Komori